Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

How new Ibrutinib data may change current practices in CLL

Editor By No Comments1 Min Read

Susan OBrien, M.D., UC Irvine Health discusses how new Ibrutinib data may change current practices in CLL from MOASC Spotlight on ASH 2017

Share.

Related Posts